Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-11-010535
Filing Date
2011-02-17
Accepted
2011-02-17 14:55:49
Documents
1
Period of Report
2011-02-08

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c12852_4ax0.html 4/A  
1 MAIN DOCUMENT DESCRIPTION c12852_4ax0.xml 4/A 17832
  Complete submission text file 0001209191-11-010535.txt   20149
Mailing Address THE JOHN HANCOCK TOWER 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116
Business Address
GADICKE ANSBERT (Reporting) CIK: 0001134655 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35060 | Film No.: 11620577

Mailing Address P.O. BOX 70 BODEGA CA 94922
Business Address
KAILIAN VAUGHN M (Reporting) CIK: 0001180429 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35060 | Film No.: 11620578

Mailing Address 5 SYLVAN WAY SUITE 125 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 125 PARSIPPANY NJ 07054 973-254-3560
Pacira Pharmaceuticals, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations